| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 SYT9 CDH23 PCDH12 FAT1 FAT2 DST PCDH18 FAT4 NAALADL1 COMP PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PLCD4 SYT10 PCDHB16 THBS3 CELSR1 CELSR3 CELSR2 ASPH CDH2 PCDH9 CDH15 ATP5F1B CDHR4 | 3.42e-13 | 749 | 195 | 33 | GO:0005509 |
| GeneOntologyMolecularFunction | extracellularly glutamate-gated ion channel activity | 3.12e-05 | 7 | 195 | 3 | GO:0005234 | |
| GeneOntologyMolecularFunction | NMDA glutamate receptor activity | 4.95e-05 | 8 | 195 | 3 | GO:0004972 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | CDH23 DBN1 ITGB4 DST PTPRF IGSF9 DMD COMP TNC KTN1 GRIN2A GRIN2B CTNNA2 CDH2 TNXB CDH15 | 2.75e-04 | 599 | 195 | 16 | GO:0050839 |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 5.62e-04 | 4 | 195 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | glutamate-gated receptor activity | 5.64e-04 | 17 | 195 | 3 | GO:0004970 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 5.80e-04 | 105 | 195 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 9.31e-04 | 5 | 195 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 9.31e-04 | 5 | 195 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 9.31e-04 | 5 | 195 | 2 | GO:0062181 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDH23 PCDH12 PLXNB2 FAT1 FAT2 PTPRF IGSF9 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 2.00e-24 | 187 | 193 | 27 | GO:0007156 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 CDH23 PCDH12 PLXNB2 FAT1 FAT2 PTPRF IGSF9 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 1.85e-18 | 313 | 193 | 27 | GO:0098742 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 CDH23 PCDH12 PLXNB2 ITGB4 FAT1 FAT2 PTPRF IGSF9 PCDH18 FAT4 COMP PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PIP5K1C PCDHB16 CELSR1 CELSR3 CELSR2 SIGLEC1 CTNNA2 CDH2 MUC4 TNXB PCDH9 CDH15 CDHR4 | 3.99e-10 | 1077 | 193 | 34 | GO:0098609 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 6.03e-07 | 53 | 193 | 7 | GO:0016339 | |
| GeneOntologyBiologicalProcess | cell junction organization | ETV5 DBN1 CSMD2 PLXNB2 ITGB4 DST PTPRF IGSF9 PCDHGC5 FKRP TNC DOCK10 PCDHB3 SORBS1 GRIN2A GRIN2B PIP5K1C PCDHB16 EIF4G1 CHRD CTNNA2 CDH2 CDH15 | 4.31e-05 | 974 | 193 | 23 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | ETV5 DBN1 CSMD2 PLXNB2 PTPRF IGSF9 PCDHGC5 TNC DOCK10 PCDHB3 SORBS1 GRIN2A GRIN2B PCDHB16 EIF4G1 CHRD CTNNA2 CDH2 | 8.18e-05 | 685 | 193 | 18 | GO:0050808 |
| GeneOntologyCellularComponent | NMDA selective glutamate receptor complex | 6.95e-05 | 9 | 200 | 3 | GO:0017146 | |
| GeneOntologyCellularComponent | postsynaptic membrane | DBN1 CSMD2 ITGB4 GPR179 PTPRF DMD GRIN3B GRIN2A GRIN2B SLC1A7 CELSR3 CTNNA2 CDH2 | 1.51e-04 | 405 | 200 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | catenin complex | 2.37e-04 | 32 | 200 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | anchoring junction | DCHS2 DCAF6 STARD8 ASH1L DBN1 PCDH12 ITGB4 FAT1 FAT2 DST DMD DSC3 TNC SORBS1 BCAR1 PIP5K1C CSPG4 CTNNA2 CDH2 PCDH9 CDH15 | 4.56e-04 | 976 | 200 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | synaptic membrane | DBN1 CSMD2 ITGB4 GPR179 PTPRF DMD GRIN3B CNR1 GRIN2A GRIN2B PIP5K1C SLC1A7 CELSR3 CTNNA2 CDH2 | 5.14e-04 | 583 | 200 | 15 | GO:0097060 |
| GeneOntologyCellularComponent | tenascin complex | 5.40e-04 | 4 | 200 | 2 | GO:0090733 | |
| MousePheno | impaired synaptic plasticity | 1.39e-05 | 47 | 158 | 6 | MP:0001900 | |
| MousePheno | impaired synaptic physiology | 1.57e-05 | 48 | 158 | 6 | MP:0021010 | |
| MousePheno | abnormal synaptic plasticity | 1.64e-05 | 72 | 158 | 7 | MP:0004859 | |
| Domain | Cadherin | DCHS2 CDH23 PCDH12 FREM1 FREM2 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 2.61e-27 | 118 | 196 | 26 | IPR002126 |
| Domain | CA | DCHS2 CDH23 PCDH12 FREM2 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 3.92e-26 | 115 | 196 | 25 | SM00112 |
| Domain | Cadherin_CS | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 2.88e-25 | 109 | 196 | 24 | IPR020894 |
| Domain | CADHERIN_1 | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 7.34e-25 | 113 | 196 | 24 | PS00232 |
| Domain | Cadherin | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 7.34e-25 | 113 | 196 | 24 | PF00028 |
| Domain | CADHERIN_2 | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 9.21e-25 | 114 | 196 | 24 | PS50268 |
| Domain | - | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 9.21e-25 | 114 | 196 | 24 | 2.60.40.60 |
| Domain | Cadherin-like | DCHS2 CDH23 PCDH12 FAT1 FAT2 PCDH18 FAT4 PCDHGC5 DSC3 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 FAT3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 CDH2 PCDH9 CDH15 CDHR4 | 1.44e-24 | 116 | 196 | 24 | IPR015919 |
| Domain | Cadherin_2 | PCDH12 PCDH18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 PCDH9 | 7.01e-11 | 65 | 196 | 11 | PF08266 |
| Domain | Cadherin_N | PCDH12 PCDH18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 PCDH9 | 7.01e-11 | 65 | 196 | 11 | IPR013164 |
| Domain | LAM_G_DOMAIN | 4.76e-09 | 38 | 196 | 8 | PS50025 | |
| Domain | Laminin_G_2 | 7.35e-09 | 40 | 196 | 8 | PF02210 | |
| Domain | Laminin_G | 8.77e-09 | 58 | 196 | 9 | IPR001791 | |
| Domain | Cadherin_C | PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 1.11e-08 | 42 | 196 | 8 | IPR032455 |
| Domain | Cadherin_C_2 | PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 1.11e-08 | 42 | 196 | 8 | PF16492 |
| Domain | LamG | 1.64e-08 | 44 | 196 | 8 | SM00282 | |
| Domain | - | 6.00e-08 | 95 | 196 | 10 | 2.60.120.200 | |
| Domain | EGF | GPR179 FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 1.26e-06 | 235 | 196 | 13 | SM00181 |
| Domain | Cadherin_tail | 2.19e-06 | 37 | 196 | 6 | PF15974 | |
| Domain | Cadherin_CBD | 2.19e-06 | 37 | 196 | 6 | IPR031904 | |
| Domain | EGF_1 | ITGB4 FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 3.11e-06 | 255 | 196 | 13 | PS00022 |
| Domain | ConA-like_dom | CMYA5 ITGB4 FAT1 FAT2 FAT4 COMP FAT3 THBS3 CELSR1 CELSR3 CELSR2 CSPG4 | 3.59e-06 | 219 | 196 | 12 | IPR013320 |
| Domain | EGF-like_CS | ITGB4 FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 4.01e-06 | 261 | 196 | 13 | IPR013032 |
| Domain | LRRC37AB_C | 4.52e-06 | 4 | 196 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 4.52e-06 | 4 | 196 | 3 | PF14914 | |
| Domain | LRRC37_N | 4.52e-06 | 4 | 196 | 3 | IPR032754 | |
| Domain | LRRC37 | 4.52e-06 | 4 | 196 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 4.52e-06 | 4 | 196 | 3 | IPR015753 | |
| Domain | EGF_2 | ITGB4 FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 4.73e-06 | 265 | 196 | 13 | PS01186 |
| Domain | EGF_CA | 5.64e-06 | 122 | 196 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.45e-06 | 124 | 196 | 9 | IPR001881 | |
| Domain | EGF_3 | FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 7.38e-06 | 235 | 196 | 12 | PS50026 |
| Domain | EGF-like_dom | FAT1 FAT2 FAT4 COMP TNC FAT3 THBS3 CELSR1 CELSR3 CELSR2 MUC4 TNXB | 1.32e-05 | 249 | 196 | 12 | IPR000742 |
| Domain | Growth_fac_rcpt_ | 4.06e-05 | 156 | 196 | 9 | IPR009030 | |
| Domain | EGF | 5.57e-05 | 126 | 196 | 8 | PF00008 | |
| Domain | Calx_beta | 9.13e-05 | 9 | 196 | 3 | IPR003644 | |
| Domain | Calx-beta | 9.13e-05 | 9 | 196 | 3 | PF03160 | |
| Domain | HormR | 1.25e-04 | 25 | 196 | 4 | SM00008 | |
| Domain | GAIN_dom_N | 1.76e-04 | 11 | 196 | 3 | IPR032471 | |
| Domain | GAIN | 1.76e-04 | 11 | 196 | 3 | PF16489 | |
| Domain | HRM | 1.98e-04 | 28 | 196 | 4 | PF02793 | |
| Domain | COMP | 3.26e-04 | 3 | 196 | 2 | PF11598 | |
| Domain | NMDAR2_C | 3.26e-04 | 3 | 196 | 2 | PF10565 | |
| Domain | Thbs/COMP_coiled-coil | 3.26e-04 | 3 | 196 | 2 | IPR024665 | |
| Domain | NMDAR2_C | 3.26e-04 | 3 | 196 | 2 | IPR018884 | |
| Domain | ASX_HYDROXYL | 6.51e-04 | 100 | 196 | 6 | PS00010 | |
| Domain | GPCR_2_extracellular_dom | 8.00e-04 | 40 | 196 | 4 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 8.00e-04 | 40 | 196 | 4 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 8.00e-04 | 40 | 196 | 4 | PS50227 | |
| Domain | Lig_chan-Glu_bd | 8.27e-04 | 18 | 196 | 3 | PF10613 | |
| Domain | Glu/Gly-bd | 8.27e-04 | 18 | 196 | 3 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 8.27e-04 | 18 | 196 | 3 | SM00918 | |
| Domain | Iontro_rcpt | 8.27e-04 | 18 | 196 | 3 | IPR001320 | |
| Domain | Iono_rcpt_met | 8.27e-04 | 18 | 196 | 3 | IPR001508 | |
| Domain | Lig_chan | 8.27e-04 | 18 | 196 | 3 | PF00060 | |
| Domain | PBPe | 8.27e-04 | 18 | 196 | 3 | SM00079 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 8.85e-04 | 106 | 196 | 6 | IPR000152 | |
| Domain | FYrich_C | 1.07e-03 | 5 | 196 | 2 | IPR003889 | |
| Domain | FYrich_N | 1.07e-03 | 5 | 196 | 2 | IPR003888 | |
| Domain | FYRC | 1.07e-03 | 5 | 196 | 2 | SM00542 | |
| Domain | FYRN | 1.07e-03 | 5 | 196 | 2 | SM00541 | |
| Domain | TSP_3 | 1.07e-03 | 5 | 196 | 2 | PF02412 | |
| Domain | TSP3 | 1.07e-03 | 5 | 196 | 2 | PS51234 | |
| Domain | TSP_CTER | 1.07e-03 | 5 | 196 | 2 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 1.07e-03 | 5 | 196 | 2 | IPR017897 | |
| Domain | TSP_type-3_rpt | 1.07e-03 | 5 | 196 | 2 | IPR028974 | |
| Domain | Cyt_P450_E_grp-II | 1.07e-03 | 5 | 196 | 2 | IPR002402 | |
| Domain | - | 1.07e-03 | 5 | 196 | 2 | 4.10.1080.10 | |
| Domain | FYRN | 1.07e-03 | 5 | 196 | 2 | PF05964 | |
| Domain | FYRC | 1.07e-03 | 5 | 196 | 2 | PF05965 | |
| Domain | Thrombospondin_C | 1.07e-03 | 5 | 196 | 2 | IPR008859 | |
| Domain | FYRC | 1.07e-03 | 5 | 196 | 2 | PS51543 | |
| Domain | FYRN | 1.07e-03 | 5 | 196 | 2 | PS51542 | |
| Domain | TSP_C | 1.07e-03 | 5 | 196 | 2 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 1.07e-03 | 5 | 196 | 2 | IPR003367 | |
| Domain | Cyt_P450_E_CYP3A | 1.60e-03 | 6 | 196 | 2 | IPR008072 | |
| Domain | Val/Leu/Ile-tRNA-synth_edit | 1.60e-03 | 6 | 196 | 2 | IPR009008 | |
| Domain | Anticodon_1 | 1.60e-03 | 6 | 196 | 2 | PF08264 | |
| Domain | M/V/L/I-tRNA-synth_anticd-bd | 1.60e-03 | 6 | 196 | 2 | IPR013155 | |
| Domain | - | 1.60e-03 | 6 | 196 | 2 | 3.90.740.10 | |
| Domain | fn3 | 1.63e-03 | 162 | 196 | 7 | PF00041 | |
| Domain | 7tm_2 | 1.86e-03 | 50 | 196 | 4 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 1.86e-03 | 50 | 196 | 4 | PS00650 | |
| Domain | EGF_CA | 2.12e-03 | 86 | 196 | 5 | PF07645 | |
| Domain | Cadherin_C | 2.21e-03 | 25 | 196 | 3 | PF01049 | |
| Domain | Cadherin_cytoplasmic-dom | 2.21e-03 | 25 | 196 | 3 | IPR000233 | |
| Domain | aa-tRNA-synth_Ia | 2.22e-03 | 7 | 196 | 2 | IPR002300 | |
| Domain | tRNA-synt_1 | 2.22e-03 | 7 | 196 | 2 | PF00133 | |
| Domain | Cadherin_pro | 2.22e-03 | 7 | 196 | 2 | PF08758 | |
| Domain | Cadherin_pro | 2.94e-03 | 8 | 196 | 2 | SM01055 | |
| Domain | Calx_beta | 2.94e-03 | 8 | 196 | 2 | SM00237 | |
| Domain | Cadherin_pro_dom | 2.94e-03 | 8 | 196 | 2 | IPR014868 | |
| Domain | Catenin_binding_dom | 3.40e-03 | 29 | 196 | 3 | IPR027397 | |
| Domain | - | 3.40e-03 | 29 | 196 | 3 | 4.10.900.10 | |
| Domain | FN3 | 3.44e-03 | 185 | 196 | 7 | SM00060 | |
| Domain | EGF_Ca-bd_CS | 3.57e-03 | 97 | 196 | 5 | IPR018097 | |
| Domain | GPCR_2_secretin-like | 3.63e-03 | 60 | 196 | 4 | IPR000832 | |
| Domain | GPCR_2-like | 3.63e-03 | 60 | 196 | 4 | IPR017981 | |
| Domain | EGF_LAM_2 | 3.75e-03 | 30 | 196 | 3 | PS50027 | |
| Domain | EGF_LAM_1 | 3.75e-03 | 30 | 196 | 3 | PS01248 | |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | PCDH12 FAT2 PCDH18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 PCDH9 | 8.12e-19 | 80 | 202 | 15 | 10716726 |
| Pubmed | PCDH12 FAT2 PCDH18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 CELSR1 CELSR2 PCDH9 | 1.92e-17 | 77 | 202 | 14 | 10835267 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | PCDH12 FAT2 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 CELSR1 CELSR3 CELSR2 | 3.04e-16 | 72 | 202 | 13 | 10380929 |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | PCDH12 PCDH18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 PCDH9 | 5.86e-13 | 74 | 202 | 11 | 10817752 |
| Pubmed | KIAA0232 RAP1GAP2 POGZ CRACD PLEKHM2 MICAL3 KIF17 ANKFY1 LRCH2 DOCK10 SORBS1 PIP5K1C VIRMA PCDHB16 ARFGEF3 PPIP5K1 YY1AP1 MAPKBP1 VPS13B | 4.02e-12 | 407 | 202 | 19 | 12693553 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 6.49e-12 | 67 | 202 | 10 | 21875946 | |
| Pubmed | 1.31e-10 | 7 | 202 | 5 | 16059920 | ||
| Pubmed | DBN1 FER1L6 FAT2 DST MDN1 DMD FAT3 VIRMA IGF2BP1 IGF2BP3 GTF2I PPIP5K1 VPS13B | 1.36e-09 | 234 | 202 | 13 | 36243803 | |
| Pubmed | AKAP8 UGGT1 NACA PSMD4 CRACD NCAPG DST MDN1 PELO NUP210 GNL2 OS9 MICAL3 SCFD1 TRMT1L IPO8 FLYWCH2 KTN1 ARFGEF3 IGF2BP1 MRPL18 IARS2 IGF2BP3 GTF2I ASPH EIF4G1 CTNNA2 VPS53 ATP5F1B | 5.83e-09 | 1440 | 202 | 29 | 30833792 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 6.18e-09 | 68 | 202 | 8 | 11230163 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | RAP1GAP2 ANKHD1 PLXNB2 BIRC6 CNTROB ITGB4 KMT2C FAT1 SLC38A10 DST MDN1 PTPRF PLEKHM2 MICAL3 RIC1 INO80 LARS2 PIP5K1C CELSR1 CELSR3 CELSR2 ZNF408 CSPG4 EIF4G1 MAPKBP1 | 7.58e-09 | 1105 | 202 | 25 | 35748872 |
| Pubmed | CAAP1 AKAP8 NACA ZMYM2 TEX10 ANKHD1 CRACD KMT2C GUF1 DST MDN1 INTS2 GNL2 GOLIM4 OS9 TRMT1L FHIP1A C8orf33 ZNF574 KTN1 INO80 ZFC3H1 VIRMA CELSR1 CTR9 ASPH EIF4G1 CTNNA2 ATP5F1B | 1.37e-08 | 1497 | 202 | 29 | 31527615 | |
| Pubmed | Differential expression of individual gamma-protocadherins during mouse brain development. | 3.81e-08 | 7 | 202 | 4 | 15964765 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | CAAP1 AKAP8 ZMYM2 POGZ DBN1 WWC2 MDN1 FIP1L1 MICAL3 SCFD1 BIN1 ZEB1 VIRMA GTF2I CTR9 ASPH EIF4G1 YY1AP1 KDM4B | 1.55e-07 | 774 | 202 | 19 | 15302935 |
| Pubmed | Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes. | 1.93e-07 | 3 | 202 | 3 | 15744052 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 11677057 | ||
| Pubmed | Making of a Synapse: Recurrent Roles of Drebrin A at Excitatory Synapses Throughout Life. | 1.93e-07 | 3 | 202 | 3 | 28865018 | |
| Pubmed | AKAP8 NACA ZMYM2 ETV5 PSMD4 POGZ DBN1 TEX10 ANKHD1 KMT2C FAT1 DST GNL2 FIP1L1 TRMT1L ZEB1 INO80 IGF2BP1 IGF2BP3 GTF2I DGKK ZKSCAN3 EIF4G1 ZSCAN18 YY1AP1 SLX4 | 2.78e-07 | 1429 | 202 | 26 | 35140242 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | STARD8 CYP3A4 CYP3A5 CDH23 DENND1C DBN1 PLXNB2 SLC38A10 MDN1 INTS2 PLEKHM2 CARD9 OS9 FHIP1A GRIN2A PIP5K1C VIRMA SLC16A2 CTR9 ZNF408 PLET1 VPS53 SLX4 KDM4B | 2.85e-07 | 1242 | 202 | 24 | 30973865 |
| Pubmed | The adhesion GPCRs CELSR1-3 and LPHN3 engage G proteins via distinct activation mechanisms. | 7.69e-07 | 4 | 202 | 3 | 37224017 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 22419166 | ||
| Pubmed | Developmental expression profiles of Celsr (Flamingo) genes in the mouse. | 7.69e-07 | 4 | 202 | 3 | 11850187 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 12008020 | ||
| Pubmed | AKAP8 ZMYM2 DBN1 TEX10 DST MDN1 BIN1 ZEB1 ANKFY1 LRCH2 KTN1 SORBS1 GRIN2A GRIN2B VIRMA CELSR2 EIF4G1 ZSCAN18 CTNNA2 CDH2 | 1.00e-06 | 963 | 202 | 20 | 28671696 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.01e-06 | 57 | 202 | 6 | 32633719 | |
| Pubmed | 1.43e-06 | 15 | 202 | 4 | 23515096 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | BDP1 DCHS2 TEX10 KMT2C MDN1 GNL2 MICAL3 C8orf33 RIC1 KTN1 SORBS1 ZNF408 MUC4 KDM4B | 1.46e-06 | 497 | 202 | 14 | 36774506 |
| Pubmed | ZMYM2 POGZ DBN1 ANKHD1 CRACD INTS2 NRK SIK2 FIP1L1 USP1 RNF208 RIC1 BIN1 MANEA SORBS1 MRPL18 YY1AP1 | 2.12e-06 | 750 | 202 | 17 | 11230166 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | AKAP8 NACA TEX10 BIRC6 MDN1 GNL2 TRMT1L HSF2 C8orf33 IPO8 KTN1 ZFC3H1 VIRMA IGF2BP1 IGF2BP3 ASPH EIF4G1 | 2.48e-06 | 759 | 202 | 17 | 35915203 |
| Pubmed | 2.48e-06 | 103 | 202 | 7 | 10574462 | ||
| Pubmed | GGA2 NACA POGZ ANKHD1 KMT2C DST INTS2 TECPR2 IGSF9 SCFD1 SASH1 INO80 CELSR3 KDM4B | 3.01e-06 | 529 | 202 | 14 | 14621295 | |
| Pubmed | Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development. | 3.17e-06 | 18 | 202 | 4 | 33108146 | |
| Pubmed | GGA2 AKAP8 BIRC6 DMXL1 FAT1 DST PLEKHM2 FIP1L1 SCFD1 FAT4 AFF2 ARFGEF3 IGF2BP1 IARS2 IGF2BP3 GTF2I PCDH9 | 3.39e-06 | 777 | 202 | 17 | 35844135 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NACA PSMD4 POGZ TEX10 ANKHD1 BIRC6 GUF1 NCAPG DST MDN1 FBXL18 PELO FIP1L1 SCFD1 ANKFY1 DSC3 KTN1 DOCK10 GTF2I CTR9 ASPH EIF4G1 ATP5F1B | 4.42e-06 | 1353 | 202 | 23 | 29467282 |
| Pubmed | AKAP8 NACA PSMD4 DBN1 RB1CC1 FIP1L1 C8orf33 ANKFY1 IPO8 IGF2BP1 IGF2BP3 GTF2I EIF4G1 ATP5F1B | 4.79e-06 | 551 | 202 | 14 | 34728620 | |
| Pubmed | KIAA0232 RAP1GAP2 ZMYM2 PSMD4 POGZ ITGB4 KMT2C DST OS9 DMD KTN1 SORBS1 YY1AP1 | 6.09e-06 | 486 | 202 | 13 | 20936779 | |
| Pubmed | AKAP8 UGGT1 RB1CC1 PLXNB2 DMXL1 GUF1 NCAPG MDN1 NUP210 RETREG1 GNL2 SIK2 OS9 SCFD1 IPO8 DSC3 KTN1 ZFC3H1 ARMC1 IARS2 CTR9 ASPH VPS13B ATP5F1B | 6.47e-06 | 1487 | 202 | 24 | 33957083 | |
| Pubmed | DCHS2 DCAF6 ASH1L RAP1GAP2 ZMYM2 PSMD4 POGZ CMYA5 GUF1 DST RETREG1 FIP1L1 BIN1 SORBS1 GRIN2B ZFC3H1 CELSR3 CTR9 EIF4G1 YY1AP1 SLX4 ATP5F1B | 6.48e-06 | 1285 | 202 | 22 | 35914814 | |
| Pubmed | HIV-1 Tat causes apoptotic death and calcium homeostasis alterations in rat neurons. | 6.64e-06 | 7 | 202 | 3 | 11606043 | |
| Pubmed | Early embryonic expression patterns of the mouse Flamingo and Prickle orthologues. | 6.64e-06 | 7 | 202 | 3 | 17937400 | |
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 6.64e-06 | 7 | 202 | 3 | 22510986 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 12775422 | ||
| Pubmed | The cell adhesion molecule M-cadherin is not essential for muscle development and regeneration. | 6.64e-06 | 7 | 202 | 3 | 12052883 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 10197777 | ||
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 12414113 | ||
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 14644469 | ||
| Pubmed | Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. | 6.64e-06 | 7 | 202 | 3 | 7569905 | |
| Pubmed | HIV immune complexes prevent excitotoxicity by interaction with NMDA receptors. | 6.64e-06 | 7 | 202 | 3 | 22940423 | |
| Pubmed | HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. | 6.64e-06 | 7 | 202 | 3 | 11483648 | |
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 6.64e-06 | 7 | 202 | 3 | 9182820 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 22833210 | ||
| Pubmed | DCAF6 CMYA5 PCDH12 BIRC6 DST RETREG1 OS9 USP1 GPD1 BIN1 ANKFY1 KTN1 SORBS1 | 7.74e-06 | 497 | 202 | 13 | 23414517 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | UGGT1 PLXNB2 ITGB4 DMXL1 FAT1 PTPRF NUP210 GOLIM4 PCSK9 FAT4 FKRP KTN1 MANEA THBS3 CELSR1 CELSR3 CELSR2 CSPG4 ASPH CDH2 ATP5F1B | 7.75e-06 | 1201 | 202 | 21 | 35696571 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | ZMYM2 PSMD4 POGZ TEX10 PLXNB2 PTPRF INTS2 NUP210 GOLIM4 ZNF574 ZEB1 IPO8 KTN1 ZFC3H1 VIRMA CSPG4 ASPH EIF4G1 CDH2 SLX4 ATP5F1B | 7.94e-06 | 1203 | 202 | 21 | 29180619 |
| Pubmed | IL12RB2 CAAP1 DCAF6 AKAP8 ASH1L POGZ ANKHD1 PAGE5 ZNF469 FAT1 PELO GNL2 FIP1L1 ZNF574 FAT3 ZKSCAN2 INO80 SIGLEC1 VPS53 CDH15 | 9.04e-06 | 1116 | 202 | 20 | 31753913 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 8563977 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 7695237 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 14602821 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 8724036 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 16489129 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 8822372 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 10448428 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 8955056 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 10555109 | ||
| Pubmed | Direct cytotoxicity of HIV-1 envelope protein gp120 on human NT neurons. | 1.06e-05 | 8 | 202 | 3 | 8804048 | |
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 9651389 | ||
| Pubmed | 1.06e-05 | 8 | 202 | 3 | 8845955 | ||
| Pubmed | HIV-1 gp120-induced neurotoxicity to midbrain dopamine cultures. | 1.06e-05 | 8 | 202 | 3 | 8821747 | |
| Pubmed | Stromal Fat4 acts non-autonomously with Dchs1/2 to restrict the nephron progenitor pool. | 1.07e-05 | 24 | 202 | 4 | 26116661 | |
| Pubmed | UGGT1 ASH1L DBN1 TEX10 FER1L6 DST MDN1 RETREG1 DMD USP1 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 KTN1 ZFC3H1 CTR9 DGKK CSPG4 EIF4G1 ATP5F1B | 1.24e-05 | 1442 | 202 | 23 | 35575683 | |
| Pubmed | UGGT1 PSMD4 RB1CC1 TEX10 BIRC6 CNTROB WWC2 NCAPG PTPRF NUP210 GNL2 GOLIM4 MICAL3 DMD USP1 DSC3 DUSP8 BCAR1 CTR9 | 1.32e-05 | 1049 | 202 | 19 | 27880917 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | CAAP1 KIAA0232 NACA PSMD4 RB1CC1 GUF1 FAT1 MDN1 PTPRF INTS2 GOLIM4 SCFD1 DSC3 FKRP IARS2 CELSR2 CTNNA2 PCDH9 ATP5F1B | 1.55e-05 | 1061 | 202 | 19 | 33845483 |
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 9693030 | ||
| Pubmed | Identification of genetic variants associated with response to statin therapy. | 1.58e-05 | 9 | 202 | 3 | 19667110 | |
| Pubmed | 1.58e-05 | 9 | 202 | 3 | 21491143 | ||
| Pubmed | D1/NMDA receptors and concurrent methamphetamine+ HIV-1 Tat neurotoxicity. | 1.58e-05 | 9 | 202 | 3 | 22552781 | |
| Pubmed | Genome-wide association study of smoking initiation and current smoking. | 1.58e-05 | 9 | 202 | 3 | 19268276 | |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | ZMYM2 PSMD4 PLXNB2 LPIN1 PELO PTPRF FIP1L1 DMD ARFGEF3 IARS2 | 1.64e-05 | 313 | 202 | 10 | 38270169 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | AKAP8 UGGT1 PSMD4 ANKHD1 WWC2 PTPRF NUP210 GOLIM4 OS9 DMD PIPSL KPNA5 IPO8 IGF2BP1 GTF2I CTR9 ASPH ATP5F1B | 1.73e-05 | 974 | 202 | 18 | 28675297 |
| Pubmed | Interaction with protocadherin-gamma regulates the cell surface expression of protocadherin-alpha. | 2.03e-05 | 28 | 202 | 4 | 15347688 | |
| Pubmed | Maternal DNA Methylation Regulates Early Trophoblast Development. | 2.03e-05 | 28 | 202 | 4 | 26812015 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | BDP1 DCAF6 KIAA0232 ASH1L KMT2C INTS2 TECPR2 ANKAR NUP210 OS9 IGSF9 MICAL3 RIC1 BCAR1 PCDHB16 ARFGEF3 GTF2I ASPH ZFHX2 TANGO2 VPS13B CDH15 KDM4B | 2.05e-05 | 1489 | 202 | 23 | 28611215 |
| Pubmed | CTCF Governs the Identity and Migration of MGE-Derived Cortical Interneurons. | 2.24e-05 | 58 | 202 | 5 | 30377227 | |
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 19332541 | ||
| Pubmed | 2.25e-05 | 10 | 202 | 3 | 23064749 | ||
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 2.48e-05 | 262 | 202 | 9 | 36880596 | |
| Pubmed | HIV-1 Tat-mediated apoptosis in human blood-retinal barrier-associated cells. | 3.08e-05 | 11 | 202 | 3 | 24739951 | |
| Pubmed | A dual role for planar cell polarity genes in ciliated cells. | 3.08e-05 | 11 | 202 | 3 | 25024228 | |
| Pubmed | 3.08e-05 | 11 | 202 | 3 | 8581564 | ||
| Pubmed | 3.08e-05 | 11 | 202 | 3 | 21989910 | ||
| Pubmed | 3.08e-05 | 11 | 202 | 3 | 12531901 | ||
| Pubmed | Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. | 3.08e-05 | 11 | 202 | 3 | 16481105 | |
| Pubmed | UGGT1 POGZ TEX10 ANKHD1 BIRC6 DST MDN1 NUP210 GNL2 VIRMA IARS2 IGF2BP3 GTF2I EIF4G1 | 3.16e-05 | 653 | 202 | 14 | 22586326 | |
| Pubmed | AKAP8 ZMYM2 POGZ TEX10 GNL2 FIP1L1 FLYWCH2 ZDBF2 GTF2I YY1AP1 | 3.23e-05 | 339 | 202 | 10 | 30415952 | |
| Pubmed | 3.33e-05 | 153 | 202 | 7 | 10718198 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 27225724 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 25131300 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 28704257 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 15900284 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 10320483 | ||
| Interaction | PCDHGB1 interactions | FREM2 PTPRF PCDH18 FAT4 PCDHGB5 PCDHGB3 PCDHB16 CELSR1 CELSR3 CELSR2 PCDH9 | 2.63e-10 | 77 | 200 | 11 | int:PCDHGB1 |
| Interaction | DCANP1 interactions | 3.89e-10 | 19 | 200 | 7 | int:DCANP1 | |
| Interaction | RYK interactions | FREM2 DST PTPRF PCDH18 FAT4 DSC3 PCDHGB5 FAT3 CELSR1 CELSR3 CELSR2 CSPG4 CTNNA2 CDH2 PCDH9 | 3.44e-09 | 212 | 200 | 15 | int:RYK |
| Interaction | XAGE1A interactions | 5.90e-09 | 41 | 200 | 8 | int:XAGE1A | |
| Interaction | C2CD4B interactions | 1.07e-08 | 44 | 200 | 8 | int:C2CD4B | |
| Interaction | DKKL1 interactions | ITGB4 FREM2 FAT1 MDN1 INTS2 SCFD1 FAT4 FAT3 CELSR1 CELSR3 CELSR2 | 1.39e-08 | 111 | 200 | 11 | int:DKKL1 |
| Interaction | NUP210P1 interactions | 1.72e-07 | 42 | 200 | 7 | int:NUP210P1 | |
| Interaction | ADAMTS13 interactions | 1.73e-07 | 26 | 200 | 6 | int:ADAMTS13 | |
| Interaction | LOC254896 interactions | 2.03e-07 | 43 | 200 | 7 | int:LOC254896 | |
| Interaction | CD160 interactions | 4.45e-07 | 48 | 200 | 7 | int:CD160 | |
| Interaction | SPSB4 interactions | 4.52e-07 | 124 | 200 | 10 | int:SPSB4 | |
| Interaction | ZBBX interactions | 5.31e-07 | 31 | 200 | 6 | int:ZBBX | |
| Interaction | NXPH2 interactions | 7.85e-07 | 33 | 200 | 6 | int:NXPH2 | |
| Interaction | CBX6 interactions | KIAA0232 CDH23 TEX10 ANKHD1 TRMT1L C8orf33 PCDHGB5 PCDHGA4 FAT3 PCDHB3 VIRMA PCDHB16 IGF2BP1 IGF2BP3 | 9.64e-07 | 283 | 200 | 14 | int:CBX6 |
| Interaction | OTUD7A interactions | 1.67e-06 | 58 | 200 | 7 | int:OTUD7A | |
| Interaction | RPL23 interactions | UGGT1 CDH23 ISLR PCDH12 GNL2 FAT4 PCDHGC5 PAGE4 PCDHGB5 PCDHGA4 FAT3 PCDHB3 VIRMA PCDHB16 IGF2BP3 THBS3 CELSR2 EIF4G1 CDHR4 | 1.98e-06 | 540 | 200 | 19 | int:RPL23 |
| Interaction | PSG8 interactions | 2.98e-06 | 41 | 200 | 6 | int:PSG8 | |
| Interaction | C2CD4A interactions | 6.27e-06 | 13 | 200 | 4 | int:C2CD4A | |
| Interaction | SIRT6 interactions | AKAP8 KIAA0232 TEX10 FAT1 NUP210 GNL2 FIP1L1 TRMT1L FAT4 LRCH2 FAT3 ZDBF2 ZFC3H1 CELSR1 GTF2I CELSR3 CELSR2 CTR9 SLX4 | 1.70e-05 | 628 | 200 | 19 | int:SIRT6 |
| Interaction | PCDHGB7 interactions | 1.88e-05 | 6 | 200 | 3 | int:PCDHGB7 | |
| Interaction | LAG3 interactions | 2.02e-05 | 17 | 200 | 4 | int:LAG3 | |
| Interaction | NXPH3 interactions | 2.33e-05 | 58 | 200 | 6 | int:NXPH3 | |
| Interaction | PTPRU interactions | 3.37e-05 | 124 | 200 | 8 | int:PTPRU | |
| Interaction | CDON interactions | 4.94e-05 | 21 | 200 | 4 | int:CDON | |
| Interaction | SSX6P interactions | 5.20e-05 | 8 | 200 | 3 | int:SSX6P | |
| Interaction | SMYD2 interactions | 5.35e-05 | 67 | 200 | 6 | int:SMYD2 | |
| Interaction | DTX4 interactions | 5.99e-05 | 22 | 200 | 4 | int:DTX4 | |
| Interaction | PCDH12 interactions | 5.99e-05 | 22 | 200 | 4 | int:PCDH12 | |
| Interaction | LINC01588 interactions | 5.99e-05 | 22 | 200 | 4 | int:LINC01588 | |
| Interaction | UCN3 interactions | 7.19e-05 | 23 | 200 | 4 | int:UCN3 | |
| Interaction | PCDHGB2 interactions | 7.26e-05 | 44 | 200 | 5 | int:PCDHGB2 | |
| Interaction | CMA1 interactions | 9.02e-05 | 46 | 200 | 5 | int:CMA1 | |
| Interaction | FBXO22 interactions | BDP1 DCHS2 TEX10 KMT2C MDN1 GNL2 MICAL3 C8orf33 RIC1 KTN1 SORBS1 BCAR1 ZNF408 CHEK2 MUC4 KDM4B | 1.03e-04 | 540 | 200 | 16 | int:FBXO22 |
| Interaction | GRIN3A interactions | 1.10e-04 | 10 | 200 | 3 | int:GRIN3A | |
| Interaction | TMTC4 interactions | 1.48e-04 | 51 | 200 | 5 | int:TMTC4 | |
| Interaction | NUP43 interactions | ASH1L ZMYM2 POGZ TEX10 FSIP2 DST PELO GNL2 TRMT1L HSF2 ZDBF2 INO80 ZFC3H1 VIRMA GTF2I EIF4G1 SLX4 | 1.74e-04 | 625 | 200 | 17 | int:NUP43 |
| Interaction | CYP3A5 interactions | 1.98e-04 | 12 | 200 | 3 | int:CYP3A5 | |
| Interaction | DHX40 interactions | 2.00e-04 | 249 | 200 | 10 | int:DHX40 | |
| Interaction | TRGV3 interactions | 2.13e-04 | 55 | 200 | 5 | int:TRGV3 | |
| Cytoband | 5q31 | PCDH12 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 2.43e-09 | 115 | 202 | 9 | 5q31 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q31 | PCDH12 ANKHD1 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 9.49e-07 | 298 | 202 | 10 | chr5q31 |
| GeneFamily | Cadherin related | 2.24e-11 | 17 | 137 | 7 | 24 | |
| GeneFamily | Clustered protocadherins | PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 PCDHB3 PCDHB16 | 2.74e-08 | 64 | 137 | 8 | 20 |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.26e-07 | 3 | 137 | 3 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 4.26e-07 | 3 | 137 | 3 | 1189 | |
| GeneFamily | Glutamate ionotropic receptor NMDA type subunits | 1.46e-05 | 7 | 137 | 3 | 1201 | |
| GeneFamily | Non-clustered protocadherins | 8.91e-05 | 12 | 137 | 3 | 21 | |
| GeneFamily | Fibronectin type III domain containing | 2.19e-04 | 160 | 137 | 7 | 555 | |
| GeneFamily | CD molecules|Type I classical cadherins | 5.62e-04 | 5 | 137 | 2 | 1185 | |
| GeneFamily | Cytochrome P450 family 3 | 1.55e-03 | 8 | 137 | 2 | 1002 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.21e-03 | 43 | 137 | 3 | 409 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.26e-06 | 179 | 200 | 10 | M39308 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | IL12RB2 SYT9 ZMYM2 DENND1C CRACD NUP210 FIP1L1 DMD HSF2 USP1 RNF208 CNR1 CCDC40 ENOX2 ZEB1 IPO8 LRCH2 FAT3 DUSP8 ZDBF2 LARS2 IGF2BP1 IARS2 CELSR2 CDH2 | 1.75e-05 | 1060 | 197 | 25 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | IL12RB2 SYT9 ZMYM2 POGZ CRACD FAT1 PLEKHM2 FIP1L1 DMD HSF2 CNR1 CCDC40 ZEB1 IPO8 AFF2 CALCR FAT3 KTN1 ZDBF2 ZFC3H1 LARS2 IGF2BP1 THBS3 CELSR1 CELSR2 DGKK ZFHX2 CDH2 KDM4B | 2.68e-05 | 1370 | 197 | 29 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BDP1 IL12RB2 CAAP1 ZMYM2 POGZ TEX10 CRACD NCAPG MDN1 GNL2 FIP1L1 DMD HSF2 USP1 CCDC40 NAA16 ZEB1 IPO8 LRCH2 KTN1 ZDBF2 LARS2 IGF2BP1 IARS2 IGF2BP3 CDH2 KDM4B | 4.07e-05 | 1257 | 197 | 27 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.75e-05 | 139 | 197 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 6.25e-05 | 231 | 197 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | ZMYM2 ETV5 TEX10 FREM2 NCAPG MDN1 NUP210 HSF2 USP1 ZNF574 CCDC40 NAA16 KTN1 ZDBF2 BCAS1 LARS2 IGF2BP1 MRPL18 IARS2 IGF2BP3 THBS3 CELSR1 CELSR2 DGKK CDH2 | 8.07e-05 | 1164 | 197 | 25 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | IL12RB2 SYT9 ZMYM2 DENND1C CRACD NUP210 FIP1L1 DMD HSF2 USP1 RNF208 CNR1 CCDC40 ENOX2 ZEB1 IPO8 AFF2 LRCH2 CALCR FAT3 DUSP8 ZDBF2 BCAS1 LARS2 IGF2BP1 IARS2 CELSR2 CDH2 | 1.18e-04 | 1414 | 197 | 28 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-08 | 181 | 202 | 10 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-08 | 184 | 202 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-08 | 184 | 202 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-08 | 184 | 202 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.36e-08 | 196 | 202 | 10 | b8b9801181d7604871b48aebacb295d0a57a5eaf | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.76e-08 | 170 | 202 | 9 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-07 | 190 | 202 | 9 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0232 UGGT1 RAP1GAP2 PLXNB2 SLC38A10 DST PTPRF GMPPA EIF4G1 | 2.58e-07 | 193 | 202 | 9 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 |
| ToppCell | ILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.58e-07 | 193 | 202 | 9 | 084c88f08ce0ecd6c9f4334caed370eb2154f896 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | KIAA0232 UGGT1 RAP1GAP2 PLXNB2 SLC38A10 DST PTPRF GMPPA EIF4G1 | 2.58e-07 | 193 | 202 | 9 | fe451b3295d77b2bd1ac25cf29310c85835a45fe |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 198 | 202 | 9 | 0cd930e374c2c48d1991b51c025f9801b22ecee7 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.20e-07 | 198 | 202 | 9 | e0df6d6ff2a9c41d813f84a2a5ee7cb5f6fc3e30 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.34e-07 | 199 | 202 | 9 | c88a28a73f54dc571f2ff1e4b55073f83cbead2c | |
| ToppCell | Biopsy_Other_PF-Epithelial-KRT5-/KRT17+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.48e-07 | 200 | 202 | 9 | 077e6b9340686de9d0f11b035a8954e1f6a1b790 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.48e-07 | 200 | 202 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-06 | 170 | 202 | 8 | 0cc20322cb3e3e7bbd4daad8785c99f80e355c16 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-06 | 170 | 202 | 8 | 2d880223d01bde4bf777bd6f50b7d2768489075f | |
| ToppCell | AT1-AT2_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.73e-06 | 180 | 202 | 8 | 3c7b2033821f9e34e2924bd8655f566edcbcc7d3 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.96e-06 | 183 | 202 | 8 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 184 | 202 | 8 | 55dde9c4eebac2a33788c1ff1d8fe312d150fad4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.04e-06 | 184 | 202 | 8 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 184 | 202 | 8 | 7128a2be291544d3df3ed6c80f21ddda8437dcba | |
| ToppCell | droplet-Lung-30m-Mesenchymal-myofibroblast-pericyte_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-06 | 184 | 202 | 8 | d14238f7b0b55a4c8d7040bea854bd221a66ac30 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 2.49e-06 | 189 | 202 | 8 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.59e-06 | 190 | 202 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.59e-06 | 190 | 202 | 8 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-06 | 191 | 202 | 8 | b94e66ac71e73f46b0323d424e7b8b906751d584 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.70e-06 | 191 | 202 | 8 | 60ff989fe99d243a3d52955223680cdd1f1917a4 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.80e-06 | 192 | 202 | 8 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.91e-06 | 193 | 202 | 8 | 7cd9671e0ac64f7f3607f564485c63abbb7e7a63 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.03e-06 | 194 | 202 | 8 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | facs-Trachea-nan-3m-Epithelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 194 | 202 | 8 | 3701ca87c6dc9ccd7b4146e56371546174d26c36 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 194 | 202 | 8 | 65f9bf126be26114c2c3f4c46d48318986212a92 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 3.03e-06 | 194 | 202 | 8 | 8fc98d2c9d94f3bc6292265e20ab71c4f1f37bb3 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.03e-06 | 194 | 202 | 8 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 195 | 202 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.15e-06 | 195 | 202 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-06 | 195 | 202 | 8 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Basal_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.27e-06 | 196 | 202 | 8 | 3b66f3a79b3f2ebacb4ad646f179e505ab38d6f0 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.27e-06 | 196 | 202 | 8 | 2029f58ce6a7b8c35d3a7496c3341391990909ce | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_osteo-stroma-early_osteoblast|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.39e-06 | 197 | 202 | 8 | 2ca5ebb708935a90b12b8e98a22ae2d664ed002e | |
| ToppCell | Basal_cells|World / lung cells shred on cell class, cell subclass, sample id | 3.39e-06 | 197 | 202 | 8 | 24360b660000bdfb999d58fbf4e29585a97e1785 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.52e-06 | 198 | 202 | 8 | 12cd9f0bbad8dce5199ebfed1c4a8080710ca055 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.65e-06 | 199 | 202 | 8 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | 67dcbd86fbc79fd585d0793f979e4aac100326c9 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 3.79e-06 | 200 | 202 | 8 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 3.79e-06 | 200 | 202 | 8 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | wk_15-18-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor_intermediate_|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.06e-05 | 165 | 202 | 7 | f6887c64af0f26e33316bc5587487e24d76ece2a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-05 | 172 | 202 | 7 | 03a0aff6b7971093a4347b5ed12546d78374c56f | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_mature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.42e-05 | 115 | 202 | 6 | c3f6efb90d5ee01af831f65e240505faa6a71dc0 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 173 | 202 | 7 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | wk_20-22-Epithelial-PNS|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.44e-05 | 173 | 202 | 7 | 17b1a6b0318925d5d920f2c0a791745b9587ebef | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 173 | 202 | 7 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-05 | 173 | 202 | 7 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-05 | 175 | 202 | 7 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 175 | 202 | 7 | 2a53d4f140d5ab096efe8118d8aa351db7838b49 | |
| ToppCell | facs-Lung-3m-Mesenchymal-myofibroblast-pericyte_cell-pericyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.55e-05 | 175 | 202 | 7 | fb91a45763e4c48d993094a13088ffc19f1e2574 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 176 | 202 | 7 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.61e-05 | 176 | 202 | 7 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-05 | 177 | 202 | 7 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | metastatic_Brain-Fibroblasts-Undetermined|metastatic_Brain / Location, Cell class and cell subclass | 1.67e-05 | 177 | 202 | 7 | 54f39be5d90363cfd44dea1a96ae06d3143aa795 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-05 | 177 | 202 | 7 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.67e-05 | 177 | 202 | 7 | ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.79e-05 | 179 | 202 | 7 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Pericyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 179 | 202 | 7 | 7078022e60faa86444f2a2c6eb9f767cc66b5cfa | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-pericyte_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-05 | 179 | 202 | 7 | d4a975d8ffa5e77fb5c0ec05bf9c8f843c77ce07 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.86e-05 | 180 | 202 | 7 | b6efdb4d319ef6f87f559acd974e5a71b06a2322 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.99e-05 | 182 | 202 | 7 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-05 | 182 | 202 | 7 | d6740bca2b974122b8451989365a94a81140afd1 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | a512863304fad80acaab60a8c6107eb7c9cbac99 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.99e-05 | 182 | 202 | 7 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Macroglial-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 182 | 202 | 7 | c00e503f442d44fbae73c5e2dc85be69e294e67a | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.07e-05 | 183 | 202 | 7 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.07e-05 | 183 | 202 | 7 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.07e-05 | 183 | 202 | 7 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 184 | 202 | 7 | 45ff845ceed5960a997545c1009012b65e377d50 | |
| ToppCell | facs-Trachea-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.14e-05 | 184 | 202 | 7 | 2cc2646dee3c6001f7c10b7449c17d1935021958 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.22e-05 | 185 | 202 | 7 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.22e-05 | 185 | 202 | 7 | e0172e0ab0f1d7151a3c3c63bb7c84d6bda92035 | |
| ToppCell | Mesenchymal_cells-Osteo-CAR|World / Lineage and Cell class | 2.22e-05 | 185 | 202 | 7 | 16f1588893d09c864e0cb4f837a1b972a1a57baa | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 186 | 202 | 7 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-05 | 186 | 202 | 7 | a1ab273b01971d6a892912560d387685dd657179 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | ef3c85c01bc3da408ae288b6e3096ad888a12e63 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | facs-Trachea-nan-3m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.37e-05 | 187 | 202 | 7 | fe9fc21192ede2eea61f419d20ccda254569d0a6 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.37e-05 | 187 | 202 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | 2.37e-05 | 187 | 202 | 7 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 188 | 202 | 7 | 0d86044bc340e3efb90d0022dd299873639d831c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 188 | 202 | 7 | 61422c7919ca0ea02d6be4302f11b169a3ce35e5 | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.46e-05 | 188 | 202 | 7 | beb2df2332a46cc81b10e8e29fc9829020111f03 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-05 | 188 | 202 | 7 | 18698f0b22ccbc2b93759acc1c8dbdb30a6b5a16 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.50e-05 | 127 | 202 | 6 | f808c727c0817ed10e76eaffa9493a516e9a6b50 | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 189 | 202 | 7 | ee15b4fb3a1cfda80bcf210a23f04f242594015e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial-respiratory_basal_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.54e-05 | 189 | 202 | 7 | dc6f6fae84347d145bea71b49eaeeb3028e9c4ae | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.54e-05 | 189 | 202 | 7 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.54e-05 | 189 | 202 | 7 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.63e-05 | 190 | 202 | 7 | 1004e89d99c9d46c78b7d3532d8d4aadb81a96fd | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.63e-05 | 190 | 202 | 7 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | ETV5 ZEB1 GPR22 FKRP DOCK10 SORBS1 GRIN2B ASPH ZFHX2 PCDH9 KDM4B | 8.63e-07 | 187 | 200 | 11 | 5258_UP |
| Drug | remacemide | 5.40e-06 | 14 | 200 | 4 | CID000060510 | |
| Drug | M 0772 | 6.59e-06 | 5 | 200 | 3 | CID000032485 | |
| Drug | NS-398; Down 200; 10uM; PC3; HT_HG-U133A | CYP3A4 TECPR2 RETREG1 ZNF574 FKRP THBS3 CELSR2 ZNF408 VPS53 KDM4B | 9.26e-06 | 195 | 200 | 10 | 6892_DN |
| Drug | Primidone [125-33-7]; Down 200; 18.4uM; MCF7; HT_HG-U133A | KIAA0232 NACA LPIN1 SLC38A10 FBXL18 ANKFY1 SASH1 ZNF408 CHEK2 KDM4B | 1.11e-05 | 199 | 200 | 10 | 5323_DN |
| Drug | DCHA | 1.13e-05 | 34 | 200 | 5 | CID000007582 | |
| Drug | 1,5-(diethylamino)piperidine | 1.31e-05 | 6 | 200 | 3 | CID000004025 | |
| Drug | Tenocyclidine | 2.28e-05 | 7 | 200 | 3 | DB01520 | |
| Drug | tetrazol-5-yl)glycine | 2.28e-05 | 7 | 200 | 3 | CID000126383 | |
| Drug | pentachlorothiophenol | 2.28e-05 | 7 | 200 | 3 | CID000008620 | |
| Drug | homoquinolinate | 2.28e-05 | 7 | 200 | 3 | CID003080554 | |
| Drug | S)-piperazine-2-carboxylic acid | 2.28e-05 | 7 | 200 | 3 | CID001502069 | |
| Drug | AC1NNRU4 | 2.88e-05 | 41 | 200 | 5 | CID005126051 | |
| Drug | L-687,414 | 3.62e-05 | 8 | 200 | 3 | CID000125556 | |
| Drug | 6-chloroquinoxaline-2,3-diol | 3.62e-05 | 8 | 200 | 3 | CID000081143 | |
| Drug | ES-242-1 | 3.62e-05 | 8 | 200 | 3 | CID000131976 | |
| Drug | SDZ 220-581 | 3.62e-05 | 8 | 200 | 3 | CID000128019 | |
| Drug | 3alpha5betaHS | 3.62e-05 | 8 | 200 | 3 | CID000165024 | |
| Drug | neramexane | 3.62e-05 | 8 | 200 | 3 | CID006433106 | |
| Drug | piperazine-2,3-dicarboxylic acid | 3.62e-05 | 8 | 200 | 3 | CID000280973 | |
| Drug | LY341495 | 3.65e-05 | 43 | 200 | 5 | CID006324636 | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 4.12e-05 | 186 | 200 | 9 | 5010_DN | |
| Drug | pentanol | 4.49e-05 | 23 | 200 | 4 | CID000006276 | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 4.66e-05 | 189 | 200 | 9 | 6717_DN | |
| Drug | Deptropine citrate [2169-75-7]; Down 200; 7.6uM; HL60; HT_HG-U133A | 4.86e-05 | 190 | 200 | 9 | 3144_DN | |
| Drug | Naftopidil dihydrochloride [57149-08-3]; Up 200; 8.6uM; HL60; HT_HG-U133A | 4.86e-05 | 190 | 200 | 9 | 2911_UP | |
| Drug | RS)-2-chloro-5-hydroxyphenylglycine | 5.35e-05 | 24 | 200 | 4 | CID003645780 | |
| Drug | S 840 | 5.39e-05 | 9 | 200 | 3 | CID000096338 | |
| Drug | Antimycin A [1397-94-0]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 5.71e-05 | 194 | 200 | 9 | 5472_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; PC3; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 4653_DN | |
| Drug | Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 4692_DN | |
| Drug | Dydrogesterone [152-62-5]; Down 200; 12.8uM; HL60; HT_HG-U133A | 5.94e-05 | 195 | 200 | 9 | 2156_DN | |
| Drug | Flurbiprofen [5104-49-4]; Down 200; 16.4uM; HL60; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 3095_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 2236_UP | |
| Drug | Prednisolone [50-24-8]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.18e-05 | 196 | 200 | 9 | 7424_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 6.43e-05 | 197 | 200 | 9 | 3182_DN | |
| Drug | Ticarcillin sodium [4697-14-7]; Up 200; 9.4uM; PC3; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 5829_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | CYP3A5 DENND1C ITGB4 LPIN1 NUP210 BIN1 SORBS1 PIP5K1C CELSR2 | 6.68e-05 | 198 | 200 | 9 | 6976_UP |
| Drug | Oxytetracycline dihydrate [6153-64-6]; Up 200; 8uM; HL60; HG-U133A | 6.68e-05 | 198 | 200 | 9 | 1553_UP | |
| Drug | Isradipine [75695-93-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.68e-05 | 198 | 200 | 9 | 6508_UP | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ASH1L WWC2 SLC38A10 GOLIM4 ZNF574 PIP5K1C CELSR3 MAPKBP1 PCDH9 | 6.95e-05 | 199 | 200 | 9 | 7339_DN |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 7.04e-05 | 155 | 200 | 8 | 6817_DN | |
| Drug | alpha-hydroxyalprazolam | 7.66e-05 | 10 | 200 | 3 | CID000162244 | |
| Drug | AC1L1ICP | 7.66e-05 | 10 | 200 | 3 | CID000004520 | |
| Drug | 4-hydroxymidazolam | 7.68e-05 | 2 | 200 | 2 | ctd:C042940 | |
| Drug | norverapamil | 7.68e-05 | 2 | 200 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 7.68e-05 | 2 | 200 | 2 | CID000520660 | |
| Drug | notopterol | 7.68e-05 | 2 | 200 | 2 | CID005320227 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 7.68e-05 | 2 | 200 | 2 | ctd:C114289 | |
| Drug | N-hydroxyparacetamol | 7.68e-05 | 2 | 200 | 2 | CID000045750 | |
| Drug | 6 beta-hydroxytestosterone | 7.68e-05 | 2 | 200 | 2 | ctd:C025591 | |
| Drug | CQA 206-291 | 7.68e-05 | 2 | 200 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 7.68e-05 | 2 | 200 | 2 | ctd:C009252 | |
| Drug | 2-chloropropionate | 8.65e-05 | 27 | 200 | 4 | CID000011734 | |
| Drug | CC57 | 1.00e-04 | 28 | 200 | 4 | CID000483407 | |
| Drug | EAB 515 | 1.05e-04 | 11 | 200 | 3 | CID000159489 | |
| Drug | 5-phosphonopentanoic acid | 1.05e-04 | 11 | 200 | 3 | CID002773807 | |
| Drug | oxiracetam | 1.05e-04 | 11 | 200 | 3 | CID000004626 | |
| Drug | o-difluorobenzene | 1.05e-04 | 11 | 200 | 3 | CID000009706 | |
| Drug | delta 8-THC | 1.05e-04 | 11 | 200 | 3 | CID000002977 | |
| Drug | orphenadrine | 1.32e-04 | 56 | 200 | 5 | CID000004601 | |
| Drug | CI-1041 | 1.39e-04 | 12 | 200 | 3 | CID000156328 | |
| Drug | tenocyclidine | 1.39e-04 | 12 | 200 | 3 | CID000062751 | |
| Drug | cyclofenil | 1.51e-04 | 31 | 200 | 4 | CID000002898 | |
| Drug | piperidine | 1.54e-04 | 130 | 200 | 7 | CID000008082 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 7.29e-06 | 71 | 193 | 6 | EFO_0007878, EFO_0007979 | |
| Disease | Malignant neoplasm of breast | STARD8 AKAP8 CYP3A4 LRRC37A2 DBN1 RB1CC1 LRRC37A GOLIM4 DMD PGBD3 KPNA5 ZEB1 DSC3 KTN1 MANEA SORBS1 BCAR1 THBS3 CHEK2 CDH2 VPS13B | 8.32e-06 | 1074 | 193 | 21 | C0006142 |
| Disease | obesity (implicated_via_orthology) | 1.30e-05 | 215 | 193 | 9 | DOID:9970 (implicated_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 1.51e-05 | 8 | 193 | 3 | DOID:1561 (biomarker_via_orthology) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 1.72e-05 | 49 | 193 | 5 | DOID:0060037 (implicated_via_orthology) | |
| Disease | mental development measurement | 2.02e-05 | 25 | 193 | 4 | EFO_0008230 | |
| Disease | Squamous cell carcinoma of esophagus | 3.88e-05 | 95 | 193 | 6 | C0279626 | |
| Disease | Marles Greenberg Persaud syndrome | 4.26e-05 | 2 | 193 | 2 | C1855425 | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 4.37e-05 | 11 | 193 | 3 | EFO_0007889, EFO_0009366 | |
| Disease | Joint Instability | 1.27e-04 | 3 | 193 | 2 | C0022410 | |
| Disease | Joint laxity | 1.27e-04 | 3 | 193 | 2 | C0086437 | |
| Disease | Chagas cardiomyopathy | 1.96e-04 | 44 | 193 | 4 | EFO_0005529 | |
| Disease | Fraser syndrome (implicated_via_orthology) | 2.53e-04 | 4 | 193 | 2 | DOID:0090001 (implicated_via_orthology) | |
| Disease | tacrolimus measurement | 2.53e-04 | 4 | 193 | 2 | EFO_0008458 | |
| Disease | acquired metabolic disease (implicated_via_orthology) | 2.53e-04 | 4 | 193 | 2 | DOID:0060158 (implicated_via_orthology) | |
| Disease | S-warfarin to R-warfarin ratio measurement | 4.09e-04 | 95 | 193 | 5 | EFO_0803331 | |
| Disease | mean platelet volume | STARD8 KIAA0232 NACA FBXL18 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 DOCK10 SPAG7 SORBS1 BCAS1 CTR9 CHEK2 ATP5F1B | 4.12e-04 | 1020 | 193 | 17 | EFO_0004584 |
| Disease | Epidermolysis Bullosa Simplex | 4.20e-04 | 5 | 193 | 2 | C0079298 | |
| Disease | Sarcosine measurement | 4.43e-04 | 23 | 193 | 3 | EFO_0021668 | |
| Disease | Antithrombotic agent use measurement | 4.66e-04 | 55 | 193 | 4 | EFO_0009925 | |
| Disease | Colorectal Carcinoma | STARD8 SYT9 ISLR LPIN1 KMT2C FAT1 NCAPG DMD GRIN2A SLC1A7 ZKSCAN3 EIF4G1 CHEK2 | 7.69e-04 | 702 | 193 | 13 | C0009402 |
| Disease | LDL cholesterol change measurement | 8.75e-04 | 7 | 193 | 2 | EFO_0007804 | |
| Disease | susceptibility to mononucleosis measurement | 1.10e-03 | 69 | 193 | 4 | EFO_0008403 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 1.16e-03 | 8 | 193 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Unilateral agenesis of kidney | 1.16e-03 | 8 | 193 | 2 | C0266294 | |
| Disease | glucose metabolism decline measurement, cingulate cortex measurement | 1.49e-03 | 9 | 193 | 2 | EFO_0007738, EFO_0009392 | |
| Disease | lymphocyte count | CYP3A4 CYP3A5 KIAA0232 RAP1GAP2 CDH23 PLXNB2 ZNF469 FBXL18 MICAL3 HSF2 PCDHGC5 PCDHGB7 PCDHGB5 PCDHGB3 PCDHGA4 PCDHGA3 DOCK10 CHEK2 SIGLEC1 KDM4B | 1.54e-03 | 1464 | 193 | 20 | EFO_0004587 |
| Disease | health study participation | 1.84e-03 | 195 | 193 | 6 | EFO_0010130 | |
| Disease | tenascin measurement | 1.85e-03 | 10 | 193 | 2 | EFO_0008296 | |
| Disease | aspirin use measurement | 2.12e-03 | 39 | 193 | 3 | EFO_0007013 | |
| Disease | forced expiratory volume | CYP3A4 PLXNB2 DST CARD9 MICAL3 IPO8 ZKSCAN2 GRIN2A INO80 LARS2 IGF2BP3 TNXB KDM4B | 2.18e-03 | 789 | 193 | 13 | EFO_0004314 |
| Disease | hyperhomocysteinemia (implicated_via_orthology) | 2.25e-03 | 11 | 193 | 2 | DOID:9279 (implicated_via_orthology) | |
| Disease | vascular dementia (is_marker_for) | 2.25e-03 | 11 | 193 | 2 | DOID:8725 (is_marker_for) | |
| Disease | free cholesterol in medium LDL measurement | 2.28e-03 | 40 | 193 | 3 | EFO_0022268 | |
| Disease | Autism Spectrum Disorders | 2.38e-03 | 85 | 193 | 4 | C1510586 | |
| Disease | Prostatic Neoplasms | DCAF6 CYP3A4 CYP3A5 ASH1L ETV5 KMT2C SERPINB10 BCAS1 BCAR1 CHEK2 MUC4 | 2.57e-03 | 616 | 193 | 11 | C0033578 |
| Disease | Malignant neoplasm of prostate | DCAF6 CYP3A4 CYP3A5 ASH1L ETV5 KMT2C SERPINB10 BCAS1 BCAR1 CHEK2 MUC4 | 2.57e-03 | 616 | 193 | 11 | C0376358 |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 2.69e-03 | 12 | 193 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 2.69e-03 | 12 | 193 | 2 | EFO_0008141 | |
| Disease | Intellectual Disability | 2.85e-03 | 447 | 193 | 9 | C3714756 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 3.17e-03 | 13 | 193 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | cardiovascular disease | FREM1 PCDH18 PCSK9 SORBS1 HS1BP3 IGF2BP1 GTF2I CELSR2 TANGO2 | 3.29e-03 | 457 | 193 | 9 | EFO_0000319 |
| Disease | Neurodevelopmental Disorders | 3.29e-03 | 93 | 193 | 4 | C1535926 | |
| Disease | Fanconi anemia | 3.68e-03 | 14 | 193 | 2 | cv:C0015625 | |
| Disease | pimelic acid measurement, 3-methyladipic acid measurement | 3.68e-03 | 14 | 193 | 2 | EFO_0010449, EFO_0010524 | |
| Disease | response to statin, LDL cholesterol change measurement | 4.23e-03 | 15 | 193 | 2 | EFO_0007804, GO_0036273 | |
| Disease | free cholesterol in LDL measurement | 4.31e-03 | 50 | 193 | 3 | EFO_0022266 | |
| Disease | free cholesterol in large LDL measurement | 4.56e-03 | 51 | 193 | 3 | EFO_0022176 | |
| Disease | risk-taking behaviour | CAAP1 CDH23 BIRC6 PTPRF GTF2A1L GRIN2A GRIN2B BCAS1 THBS3 ZKSCAN3 CTNNA2 TNXB | 4.66e-03 | 764 | 193 | 12 | EFO_0008579 |
| Disease | cutaneous Leishmaniasis | 4.81e-03 | 16 | 193 | 2 | EFO_0005046 | |
| Disease | free cholesterol in small LDL measurement | 5.08e-03 | 53 | 193 | 3 | EFO_0022271 | |
| Disease | obesity | 5.22e-03 | 241 | 193 | 6 | EFO_0001073 | |
| Disease | sex interaction measurement, ulcerative colitis | 5.43e-03 | 17 | 193 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | caudal anterior cingulate cortex volume measurement | 5.43e-03 | 17 | 193 | 2 | EFO_0010289 | |
| Disease | Schizophrenia | CYP3A4 CYP3A5 DBN1 RB1CC1 CMYA5 CSMD2 KIF17 CNR1 GRIN2A GRIN2B LARS2 CTNNA2 TNXB | 5.59e-03 | 883 | 193 | 13 | C0036341 |
| Disease | upper aerodigestive tract neoplasm | 5.76e-03 | 246 | 193 | 6 | EFO_0004284 | |
| Disease | essential hypertension, age at diagnosis | 5.92e-03 | 56 | 193 | 3 | EFO_0004918, MONDO_0001134 | |
| Disease | hippocampal atrophy | 5.92e-03 | 56 | 193 | 3 | EFO_0005039 | |
| Disease | Bone marrow hypocellularity | 6.08e-03 | 18 | 193 | 2 | C1855710 | |
| Disease | total lipids in large LDL | 6.22e-03 | 57 | 193 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 6.22e-03 | 57 | 193 | 3 | EFO_0021901 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TEVQGIQSPDVPEQF | 1396 | A6H8Y1 | |
| QEQAANEIPSLEEPE | 2871 | Q9NR48 | |
| PPNEAVSVVINAELA | 1711 | Q9NR09 | |
| PNAEVVTENEEFNIG | 2301 | Q7Z408 | |
| QLEAAQEAVPPADIV | 1261 | Q6UVK1 | |
| PEEVPLSAEAQAQQL | 96 | Q9H7E9 | |
| PQEPLVQDLQAAVAA | 496 | P56945 | |
| GSDPQAEQLLEEQVP | 616 | O43823 | |
| PANNQGEESAEIIPL | 451 | P30988 | |
| VNIDSLNNPQDPFVE | 191 | P20815 | |
| QPAARSQVEATEPQD | 71 | Q13202 | |
| AEQPQIGEVEESNPS | 201 | P51816 | |
| TVVLDPEGDAQIDPN | 536 | P49747 | |
| VNVTVQDINDNPPVF | 236 | Q6V0I7 | |
| LVPFQDTPVEVEQNT | 221 | Q9NVT9 | |
| EEQVPVEAEPQNIED | 131 | Q12797 | |
| NEEAAAPEAPENTVQ | 271 | Q9H8G2 | |
| TVLDVNDNDPVFTQP | 676 | Q9NYQ6 | |
| VLDVNDNPPVFEQDE | 911 | Q9HCU4 | |
| EGQEESFVPQSSVQP | 516 | Q58WW2 | |
| VNSVIAQAPPVAQEA | 1221 | P11532 | |
| EENESTALPQVLAQP | 501 | O96017 | |
| ETTFNDVQALPPDVV | 296 | Q8IV53 | |
| NPDDEEQVLSDPNLV | 41 | Q9H257 | |
| EIVDINDNNPIFDQP | 2391 | Q9H251 | |
| QPLQVALEDIDDNEP | 2706 | Q9H251 | |
| VDNPEQPFDALNIEE | 666 | Q9Y485 | |
| PENLAPGSEVVQVQA | 246 | A6H8M9 | |
| VDVQFDEGLPPILNA | 71 | P06576 | |
| DPSIVPQVDENQQQF | 511 | O15131 | |
| QEADQEQQEPVGSPE | 16 | P36021 | |
| SEITEEQVQPDAFQP | 1346 | Q4ADV7 | |
| EGVNLVIPFVPSADN | 1321 | Q9ULG1 | |
| EVNEVGVLNPNEQPT | 296 | Q8N442 | |
| LVIDANDNPPVFSQD | 231 | Q9Y5F8 | |
| EIDVQAQDLGPNSIP | 321 | Q9HCL0 | |
| IIDENDNVPVVIGPA | 566 | Q9HCL0 | |
| LDANDNAPEVVQPVL | 556 | Q9NPG4 | |
| NPVSQQLVVDENAFP | 1071 | Q7Z5J8 | |
| SDQSVNPFEDVPVVN | 416 | Q9P2R3 | |
| EVEIIDVNDNPPSFG | 151 | Q9Y5G9 | |
| VVAFVAPGESQQEEP | 21 | O60829 | |
| VNEFVIEENLSSPNP | 736 | Q8TDY2 | |
| LAVEVENQGVFQPLP | 581 | Q8TEM1 | |
| VVVDANDNPPEFLQE | 811 | Q14517 | |
| VEDQNDNAPVFVNLP | 2071 | Q14517 | |
| IIVDDINDNPPVFAQ | 2271 | Q14517 | |
| PRNDVVFQPISGEDV | 5271 | Q99102 | |
| PDGYVPQVDDIVNVV | 206 | Q8WUE5 | |
| QDEVAAVTLPLNPQE | 81 | Q8N907 | |
| TEIQAAPQPQLDFQD | 1051 | Q5KSL6 | |
| AQQETPIQFPEEVEP | 321 | O60309 | |
| QEAPAQTPEFPNVVV | 516 | O60309 | |
| VEFQGLIQPPEDQEN | 181 | Q7RTP6 | |
| EQGPAQQPQAQVEDA | 5131 | Q9NU22 | |
| VVPEAAQNNPGEEVT | 481 | Q13823 | |
| INVVPQFSGDDLVPV | 536 | Q13823 | |
| ELPQQADQESVEPVG | 3651 | Q8NEZ4 | |
| AQQETPIQFPEEVEP | 321 | A6NM11 | |
| QEAPAQTPEFPNVVV | 516 | A6NM11 | |
| AQQETPIQFPEEVEP | 321 | A6NMS7 | |
| QEAPAQTPEFPNVVV | 516 | A6NMS7 | |
| ENAELPAKQENVPQE | 996 | Q6PRD1 | |
| DPGIDPSVVKQQQEA | 6186 | Q03001 | |
| VSYIPDEQIAQGPEN | 151 | Q9NZI8 | |
| VVVPRDQTPDENDQV | 521 | Q9NZI8 | |
| PENGTEQIIVEVFEQ | 136 | Q16206 | |
| PVDSQAPEIFVGEQL | 1061 | Q5SZK8 | |
| EAQRAIEAAPQEPEQ | 86 | Q96CP2 | |
| AEIFVGVAPEQPQNL | 116 | Q99665 | |
| GATAENVPVEQIVEN | 326 | O95786 | |
| DQSPPGDNVLNVIQE | 5706 | Q5CZC0 | |
| VNIDSLNNPQDPFVE | 191 | P08684 | |
| TVDNEVQPSGPEDNV | 371 | O14498 | |
| PEVITVGATNAQDQP | 331 | Q8NBP7 | |
| VGVSQQPEDSQQDLP | 1561 | O15031 | |
| ATVEVLVEDVNDNPP | 2256 | Q9NYQ8 | |
| DIAIQVADVNDNPPR | 3411 | Q9NYQ8 | |
| DEANIPIPSQVDIFE | 1131 | Q92628 | |
| IQVDVGDVNDNAPEV | 336 | Q9Y5F6 | |
| INVTDVNDNPPNIDL | 346 | Q9HC56 | |
| AFLPAVNEVDNPNVA | 836 | Q6N069 | |
| NEVERPEEENASANP | 46 | Q6UN15 | |
| INPTNDEAPDFVVQN | 1141 | Q5H8C1 | |
| NPEATNQPVTEQEIL | 611 | Q9H0H0 | |
| PVEELGQEQPQAVAL | 451 | Q8N8W4 | |
| DDIDDVVIPAPIQQV | 61 | O94953 | |
| QQFVDNPAIIDDPNL | 491 | Q14693 | |
| AVEDDQVAPVPLNVV | 91 | Q86UP2 | |
| GQAPPDQEALQVVYE | 256 | Q9UJY4 | |
| AQVPDDEQFVPDFQS | 61 | P41161 | |
| VEEAAAIIAQRPDNP | 276 | Q16643 | |
| QVTDANDNPPVFNRD | 231 | Q9Y5G0 | |
| IVADANDNPPVFTQD | 231 | Q9Y5G1 | |
| NIPNPAQTSVVVEDL | 1576 | P16144 | |
| VVVPRDQTPDENDQV | 521 | O00425 | |
| PDVNDENGEPTDNLV | 191 | Q5SRI9 | |
| QSVLENLPGVDPNNE | 821 | A2A3N6 | |
| VNDNDPVLEQNPFDV | 2031 | Q6V1P9 | |
| EAEFQAPPEPIQQEV | 311 | O00461 | |
| INDNAPNFPTEELEI | 126 | Q9Y5H0 | |
| EVVDINDNAPEFEQP | 231 | Q9NRJ7 | |
| QVTQDGDIPNIPAEE | 231 | Q15884 | |
| PDEPLTQFLEAAQQE | 61 | Q96IJ6 | |
| EEAARPPAEAQAEVQ | 661 | Q05DH4 | |
| EEDFVLQVAAPPSIQ | 111 | Q96FT9 | |
| EEQDQVAEEGPPVQS | 171 | Q53T59 | |
| QPQVQQEEVGVENPA | 411 | P0C671 | |
| ENENDPITNIEPFFV | 411 | Q96BY6 | |
| VAIEALSANVPQPFE | 591 | P26232 | |
| LSANVPQPFEENEFI | 596 | P26232 | |
| VPVQVEQDEELPAAS | 531 | O00341 | |
| GTLAVNIEDVNDNPP | 561 | Q14574 | |
| NIEDVNDNPPEILQE | 566 | Q14574 | |
| TIIENPDVPQDFGNQ | 181 | Q5TH69 | |
| VIDPEGTIPTNFNVA | 2216 | Q8N3K9 | |
| EVGNASPEVNLNVPV | 3361 | Q8N3K9 | |
| ELEQQEAEVQGPPEA | 371 | Q6ZU35 | |
| LPVFQDQIQQPSTEE | 241 | Q4G0X9 | |
| VVQVLDENDNKPQFP | 1241 | Q8TDW7 | |
| PVEVNIEVTDVNDNP | 1866 | Q8TDW7 | |
| IEVTDVNDNPPVFTQ | 1871 | Q8TDW7 | |
| VTVDLLVNDVNDNPP | 2271 | Q8TDW7 | |
| PQEILQPEFFEAVNE | 211 | Q00597 | |
| QADVPPEILNNVGAL | 446 | Q6PD62 | |
| DNPQLVPADQVNITE | 66 | P21554 | |
| EPQANGETPQVAVIV | 216 | Q04637 | |
| PNVVAVPDVVQAAED | 71 | P21695 | |
| NSQQEPVVGDEEPAL | 251 | A4D2B0 | |
| QEEGVFAQDLEPAPI | 936 | O60336 | |
| NAVPELVDSFLQQDP | 61 | Q9H9S5 | |
| LQQDPAQPVVVAADT | 71 | Q9H9S5 | |
| VAQITAVDPDEGPNA | 1086 | Q9NYQ7 | |
| VPEIEVTVEGPNNNN | 681 | P78347 | |
| VVSIVEADPLPNNAV | 386 | Q99680 | |
| SVPQRVEDQENEPEA | 6 | O75363 | |
| VVLVIPFQNPEEQDE | 546 | O00499 | |
| QSVLENLPGVDPNNE | 336 | P55036 | |
| EGAAAQPQAVLRQPE | 946 | Q9HBR0 | |
| VQDTNEPPVFQENPL | 366 | P55291 | |
| DLSQLQQPDTVEPDA | 786 | P19022 | |
| LLETVPQNNENPSVD | 716 | Q8N137 | |
| FVDPNTEDVAVPEQG | 406 | Q5VUJ6 | |
| DQESSQPVGPVIVQQ | 36 | Q96GU1 | |
| IVVQVTPAQQQEEPE | 1246 | P10586 | |
| QVLDINDNAPEFAQP | 231 | Q9Y5E6 | |
| STVIVQVVDVNDNPP | 331 | Q9Y5E6 | |
| QENPDDQRTVPEVTG | 11 | A6NNC1 | |
| APVIQSGEQNEPARE | 296 | Q03933 | |
| QELFQDQATPSEPEI | 81 | Q9NXH3 | |
| EASAIVIQPPENATA | 21 | Q8N328 | |
| TQRQNPFNEEPAETV | 266 | Q8IWE5 | |
| ELQNRPPAVDAVVGQ | 846 | O15397 | |
| AVLTDDPLPVVDQQQ | 726 | Q9P2E2 | |
| QPLNQDPEQEEVELA | 71 | Q16626 | |
| VPEEFQGQDQVPEQQ | 516 | Q7Z2Y5 | |
| AEAEPSGPEVEQQQQ | 896 | O60391 | |
| VPDSAQAQPAILVDV | 1146 | Q2WGJ9 | |
| EAIVFDVPPENIDQI | 421 | Q86SS6 | |
| EVEVAQVQVPTPARD | 16 | Q7Z2T5 | |
| GNDIVAIIFQEENTP | 356 | Q684P5 | |
| LESQFETEPEPQEQN | 461 | Q9BRC7 | |
| EEEAAQQGPVVVSPA | 146 | O75391 | |
| PAVDPEFLQQPEVVQ | 826 | Q15031 | |
| GVQQALSQAAPIPEE | 431 | Q9H6L5 | |
| PPAEEDLQQITVQVE | 566 | O60331 | |
| QPPEQLENELEIGFS | 786 | Q96ME1 | |
| PEPNENVGDAVQTKL | 451 | Q7Z3K3 | |
| DAPVATNNPDREVQA | 76 | Q9NYZ4 | |
| VLYPQEQENEPSIGE | 281 | Q9H0K1 | |
| DNAGQVTLVPEEPED | 11 | Q9BRX2 | |
| NVADFNPETDSIPVN | 736 | Q9NSE4 | |
| PNIGQEQPVDDAAEV | 381 | Q13438 | |
| AQAEVQPAVLAPAQA | 376 | Q92502 | |
| PSFLNQTPAGEVVEV | 1381 | Q8IY92 | |
| DEQQSPPSAEQIDFV | 911 | Q8IWZ3 | |
| APIVTVGVNNDPADV | 471 | Q9BPX3 | |
| AQVTLFIPQANPDDI | 861 | Q14CN2 | |
| EPGFAEVLPNLTVQE | 356 | Q9H2X0 | |
| QAPEPENITEVEIQA | 116 | Q6UQ28 | |
| ENEDSVFQPNQPLVD | 836 | Q6AWC2 | |
| ANVAQTEDGPPEAEV | 316 | Q9C0A1 | |
| GFPRVAPEDEVIVNQ | 106 | Q9H0X6 | |
| PQVNIVEEDPLNSGD | 406 | Q9UNN4 | |
| INIAQAELNDPTDPF | 481 | C9JQI7 | |
| VPESQEPALQQEVQA | 241 | Q6ZN55 | |
| EPALQQEVQASSPAE | 246 | Q6ZN55 | |
| VQQEVASPGEDAAEP | 201 | Q9H9D4 | |
| FPELPEIQQTSEEDN | 421 | Q9BX66 | |
| QPQAVPVAGDENEVT | 1301 | P22105 | |
| GQPQVVPVAADQREV | 1616 | P22105 | |
| GVNATLPEENQPVVF | 36 | P24821 | |
| DSDVLQPVAGQPEEV | 1246 | Q9HCK1 | |
| QPVAGQPEEVVKEVS | 1251 | Q9HCK1 | |
| VDPVENEAVAPEFTN | 36 | Q9H0U6 | |
| DDLQVEPGAEQDVPT | 841 | O94885 | |
| GSPFPEVAESVQQEL | 331 | Q8WVM8 | |
| DPQEGAVVVLPADSQ | 601 | Q9NXF1 | |
| GVPQENTDPETFNVL | 536 | O15040 | |
| AEVQVSPAGPILENQ | 326 | Q9BZZ2 | |
| PQFQETPPAVLEVQE | 136 | Q9P2J2 | |
| TVVLDPEGDAQIDPN | 731 | P49746 | |
| NEAIIFDIPPENVDQ | 431 | Q6XYQ8 | |
| PEDQVNVAEGNPLTV | 26 | A0A0B4J244 | |
| PEVQLAIEQVFPSQD | 21 | Q5VIR6 | |
| QLEAAQLPEVDTPQG | 141 | Q96JG9 | |
| QQQDTAVIFPEAPEE | 131 | P37275 | |
| EERVAEPQANFNTPQ | 91 | Q9H869 | |
| DEPVFEQIENTANPS | 1286 | Q9UBW7 | |
| AAGVQQEEPETIPER | 26 | Q8TBC5 | |
| LNEEGNFEVQVSEPV | 2266 | Q7Z7G8 | |
| RQLDEPAPQVSGVDQ | 126 | Q9BRR0 | |
| EVADFQPEQVETQPR | 151 | Q63HK3 | |
| QDVEPVLSAPESLQN | 1496 | Q69YN4 | |
| NQINVPALDTVVTPD | 1321 | O60293 | |
| SEVIVDPIQGQVNFE | 16 | Q68DY9 | |
| AEPQPVNFVEASDQI | 136 | P48595 | |
| QFEIVPEDDPQNAIV | 246 | Q3YBR2 | |
| SIEGEQELFEPNQSP | 1226 | Q6PFW1 | |
| IQAFQQIAADEPPPE | 131 | Q9NYU2 | |
| SPPDADEVVIVLNNF | 1186 | Q9NYU2 | |
| EIDQVVPAAQSSPIN | 56 | O94782 | |
| VLNNEEAQLPDPAIE | 196 | Q6ICL3 | |
| LSFPSQEQPNVVDIV | 106 | Q9UQQ1 | |
| ATEQELPQPQAETAV | 11 | E9PAV3 | |
| DPPQFVENVTLPENV | 1131 | Q12879 | |
| EDNSLQELDQPAAPV | 1256 | Q13224 | |
| QELDQPAAPVAVTSN | 1261 | Q13224 |